CD4_NN
promoter_NN
transactivation_NN
by_IN
human_JJ
herpesvirus_NN
6_CD
._.

The_DT
observation_NN
that_IN
human_JJ
herpesvirus_NN
6_CD
-LRB-_-LRB-
HHV-6_NN
-RRB-_-RRB-
can_MD
induce_VB
CD4_NN
gene_NN
transcription_NN
and_CC
expression_NN
in_IN
CD4_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
cells_NNS
was_VBD
reported_VBN
several_JJ
years_NNS
ago_RB
-LRB-_-LRB-
P._NNP
Lusso_NNP
,_,
A._NNP
De_NNP
Maria_NNP
,_,
M._NNP
Malnati_NNP
,_,
F._NNP
Lori_NNP
,_,
S.E._NNP
DeRocco_NNP
,_,
M._NNP
Baseler_NNP
,_,
and_CC
R.C._NNP
Gallo_NNP
,_,
Nature_NNP
349_CD
:_:
533-535_CD
,_,
1991_CD
-RRB-_-RRB-
and_CC
subsequently_RB
confirmed_VBN
-LRB-_-LRB-
P._NNP
Lusso_NNP
,_,
M.S._NNP
Malnati_NNP
,_,
A.Garzino-Demo_NNP
,_,
R.W._NNP
Crowley_NNP
,_,
E._NNP
O._NNP
Long_NNP
,_,
and_CC
R.C._NNP
Gallo_NNP
,_,
Nature_NNP
362_CD
:_:
458-462_CD
,_,
1993_CD
;_:
G._NNP
Furlini_NNP
,_,
M._NNP
Vignoli_NNP
,_,
E._NNP
Ramazzotti_NNP
,_,
M.C._NNP
Re_NNP
,_,
G._NNP
Visani_NNP
,_,
and_CC
M._NNP
LaPlaca_NNP
,_,
Blood_NNP
87_CD
:_:
4737-4745_CD
,_,
1996_CD
-RRB-_-RRB-
._.

Our_PRP$
objective_NN
was_VBD
to_TO
identify_VB
the_DT
mechanisms_NNS
underlying_VBG
such_JJ
phenomena_NNS
._.

Using_VBG
reporter_NN
gene_NN
constructs_NNS
driven_VBN
by_IN
the_DT
CD4_NN
promoter_NN
,_,
we_PRP
report_VBP
that_IN
HHV-6_NN
can_MD
efficiently_RB
transactivate_VB
such_JJ
genetic_JJ
elements_NNS
._.

Activation_NN
of_IN
the_DT
CD4_NN
promoter_NN
occurs_VBZ
in_IN
the_DT
presence_NN
of_IN
the_DT
viral_JJ
DNA_NN
polymerase_NN
inhibitor_NN
phosphonoformic_JJ
acid_NN
,_,
which_WDT
limits_VBZ
expression_NN
to_TO
the_DT
immediate-early_JJ
and_CC
early_JJ
classes_NNS
of_IN
viral_JJ
genes_NNS
._.

Using_VBG
deletion_NN
mutants_NNS
and_CC
specific_JJ
CD4_NN
promoter_NN
mutants_NNS
,_,
we_PRP
identified_VBD
an_DT
ATF\/CRE_NN
binding_NN
site_NN
located_JJ
at_IN
nucleotides_NNS
-67_CD
to_TO
-60_CD
upstream_JJ
of_IN
the_DT
CD4_NN
gene_NN
transcription_NN
start_NN
site_NN
that_WDT
is_VBZ
important_JJ
for_IN
HHV-6_NN
transactivation_NN
._.

The_DT
ATF\/CRE_NN
site_NN
is_VBZ
also_RB
essential_JJ
for_IN
CD4_NN
promoter_NN
activation_NN
by_IN
forskolin_NN
,_,
an_DT
activator_NN
of_IN
adenylate_JJ
cyclase_NN
._.

Using_VBG
electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
and_CC
specific_JJ
antibodies_NNS
,_,
we_PRP
showed_VBD
that_IN
CREB-1_NN
binds_VBZ
specifically_RB
to_TO
the_DT
-79_CD
to_TO
-52_CD
region_NN
of_IN
the_DT
CD4_NN
promoter_NN
._.

Last_RB
,_,
we_PRP
have_VBP
identified_VBN
two_CD
open_JJ
reading_NN
frames_NNS
-LRB-_-LRB-
ORFs_NNS
-RRB-_-RRB-
of_IN
HHV-6_NN
,_,
U86_NN
and_CC
U89_NN
from_IN
the_DT
immediate-early_JJ
locus_NN
A_NN
,_,
that_WDT
can_MD
transactivate_VB
the_DT
CD4_NN
promoter_NN
in_IN
HeLa_NN
cells_NNS
._.

However_RB
,_,
transactivation_NN
of_IN
the_DT
CD4_NN
promoter_NN
by_IN
ORFs_NNS
U86_NN
and_CC
U89_NN
is_VBZ
independent_JJ
of_IN
the_DT
CRE_NN
element_NN
,_,
suggesting_VBG
that_IN
additional_JJ
HHV-6_NN
ORFs_NNS
are_VBP
likely_JJ
to_TO
contribute_VB
to_TO
CD4_NN
gene_NN
activation_NN
._.

Taken_VBN
together_RB
,_,
our_PRP$
results_NNS
will_MD
help_VB
to_TO
understand_VB
the_DT
complex_NN
interactions_NNS
occurring_VBG
between_IN
HHV-6_NN
and_CC
the_DT
CD4_NN
promoter_NN
and_CC
provide_VBP
additional_JJ
information_NN
regarding_VBG
the_DT
class_NN
of_IN
transcription_NN
factors_NNS
involved_VBN
in_IN
the_DT
control_NN
of_IN
CD4_NN
gene_NN
expression_NN
._.

